Global RNAi Therapy Supply, Demand and Key Producers, 2023-2029

Global RNAi Therapy Supply, Demand and Key Producers, 2023-2029

The global RNAi Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global RNAi Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for RNAi Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of RNAi Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global RNAi Therapy total market, 2018-2029, (USD Million)

Global RNAi Therapy total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: RNAi Therapy total market, key domestic companies and share, (USD Million)

Global RNAi Therapy revenue by player and market share 2018-2023, (USD Million)

Global RNAi Therapy total market by Type, CAGR, 2018-2029, (USD Million)

Global RNAi Therapy total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global RNAi Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alnylam, Sarepta Therapeutics, Alnylam Pharmaceuticals, Moderna, Sanofi, Arcturus Therapeutics, Silence and Sirnaomics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World RNAi Therapy market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global RNAi Therapy Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global RNAi Therapy Market, Segmentation by Type
Small Molecule Interfering Ribonucleic Acid (SiRNA)
Microrna (MiRNA)

Global RNAi Therapy Market, Segmentation by Application
Oncology
Cardiology
Others

Companies Profiled:
Alnylam
Sarepta Therapeutics
Alnylam Pharmaceuticals
Moderna
Sanofi
Arcturus Therapeutics
Silence
Sirnaomics

Key Questions Answered

1. How big is the global RNAi Therapy market?

2. What is the demand of the global RNAi Therapy market?

3. What is the year over year growth of the global RNAi Therapy market?

4. What is the total value of the global RNAi Therapy market?

5. Who are the major players in the global RNAi Therapy market?

6. What are the growth factors driving the market demand?